In Episode 2 of our 'Tea and Talk' podcast, Dr. Rebekah Widdowfield chats with the CEO of Novabiotics, Dr. Deborah O'Neil about the efficacy of creating drugs, how the vaccine development process works, current efforts being made to produce treatments for COVID-19, and how the current pandemic has affected our approach to global production and collaboration.
Subscribe for a new episode every Friday.
The Royal Society of Edinburgh — @news_RSE
Dr. Rebekah Widdowfield — @Rebekah_RSE
Dr. Deborah O'Neil — @debsoneil | @NovaBiotics
Wrapping up this series of Tea and Talk, Episode 7 features Talat Yaqoob — Independent consultant and researcher, and a member of the RSE...
'Tea and Talk' returns for Episode 4 with Dr. Stella Chan of the University of Edinburgh, and a member of the RSE Young Academy...
Episode 3 of our 'Tea and Talk' podcast dives into the social science and analysis of public behaviours during the COVID-19 pandemic, as Dr....